Historical record - last NADAC effective date: 9/18/2024
Product Information
LIDOCAINE 5% PATCH is a generic product labeled by YARAL Pharma Inc., priced at $1.9418 per EA under NDC 82347050505. Its NADAC has been published 61 times since Aug 9, 2023.
FDA first approved this application on Apr 30, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/g
Manufacturer
YARAL Pharma Inc.NDC
82347050505
Classification
Generic
Dosage Form
PATCH
Route
TOPICAL
Effective Date
9/18/2024
Active Ingredients
LIDOCAINEApproval Type
Generic (ANDA)
FDA Application
ANDA209190FDA Approved
4/30/2020
TE Code
AB
On Market Since
6/15/2023
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 5% PATCH has been published 61 times since Aug 9, 2023, and over the history we have for it it has risen 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9418 per EA |
|---|---|
| All-time high | $1.9845 (Sep 11, 2024) |
| All-time low | $1.7004 (Apr 17, 2024) |
| Median price | $1.9138 |
| Average price | $1.8725 |
| Largest weekly change | +13.9% (Aug 21, 2024) |
| Weeks tracked | 61 |
| Tracking since | Aug 9, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+1.5%
5Y
N/A
All
+6.5%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
YARAL Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine 5% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 5% PATCH?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 5% PATCH, manufactured by YARAL Pharma Inc., is $1.9418 per EA (NDC 82347050505), effective Oct 2, 2024.
How has the price of LIDOCAINE 5% PATCH changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 5% PATCH has risen 6.5%. It has been tracked across 61 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 5% PATCH?
Since Aug 9, 2023, the NADAC for LIDOCAINE 5% PATCH has ranged from a low of $1.7004 (Apr 17, 2024) to a high of $1.9845 (Sep 11, 2024), with a median of $1.9138 per EA.
Are there cheaper alternatives to LIDOCAINE 5% PATCH?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LIDOCAINE 5% PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures LIDOCAINE 5% PATCH?
LIDOCAINE 5% PATCH (NDC 82347050505) is labeled by YARAL Pharma Inc., and CMS classifies it as a generic product.